The individual did not develop the disease and does not pose a risk to the public, the medical center said.
“This person completed the required 21-day monitoring period and did not develop symptoms of the disease,” said Ted Cieslak, MD, an infectious diseases specialist at Nebraska Medicine.
The physician was admitted to the medical center Dec. 29 for monitoring after a potential Ebola exposure in the Democratic Republic of Congo.
Nebraska Medicine has monitored several people for Ebola since the virus outbreak in 2014. The Nebraska Biocontainment Unit for treatment was used to treat three Ebola patients in 2014.
More articles on clinical leadership and infection control:
Boston Children’s researchers tap machine learning for better flu surveillance
How CRISPR can help with antibiotic development
Flu has already sickened more than 6 million this season
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
